{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Phosphodiesterase inhibitors", "antidiabetic plants", "cyclic nucleotides", "diabetes", "medicinal plants.", "pancreatic \u03b2-cells"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38265379", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "08"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "08"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0115734064255060231116192839"], "ArticleDate": [], "Journal": {"ISSN": "1875-6638", "JournalIssue": {"Volume": "20", "Issue": "5", "PubDate": {"Year": "2024"}}, "Title": "Medicinal chemistry (Shariqah (United Arab Emirates))", "ISOAbbreviation": "Med Chem"}, "ArticleTitle": "A Review of Antidiabetic Medicinal Plants as a Novel Source of Phosphodiesterase Inhibitors: Future Perspective of New Challenges Against Diabetes Mellitus.", "Pagination": {"StartPage": "467", "EndPage": "486", "MedlinePgn": "467-486"}, "Abstract": {"AbstractText": ["Intracellular glucose concentration plays a crucial role in initiating the molecular secretory process of pancreatic \u03b2-cells through multiple messengers and signaling pathways. Cyclic nucleotides are key physiological regulators that modulate pathway interactions in \u03b2 -cells. An increase of cyclic nucleotides is controled by hydrolysed phosphodiesterases (PDEs), which degrades cyclic nucleotides into inactive metabolites. Despite the undeniable therapeutic potential of PDE inhibitors, they are associated with several side effects. The treatment strategy for diabetes based on PDE inhibitors has been proposed for a long time. Hence, the world of natural antidiabetic medicinal plants represents an ideal source of phosphodiesterase inhibitors as a new strategy for developing novel agents to treat diabetes mellitus. This review highlights medicinal plants traditionally used in the treatment of diabetes mellitus that have been proven to have inhibitory effects on PDE activity. The contents of this review were sourced from electronic databases, including Science Direct, PubMed, Springer Link, Web of Science, Scopus, Wiley Online, Scifinder and Google Scholar. These databases were consulted to collect information without any limitation date. After comprehensive literature screening, this paper identified 27 medicinal plants that have been reported to exhibit anti-phosphodiesterase activities. The selection of these plants was based on their traditional uses in the treatment of diabetes mellitus. The review emphasizes the antiphosphodiesterase properties of 31 bioactive components derived from these plant extracts. Many phenolic compounds have been identified as PDE inhibitors: Brazilin, mesozygin, artonin I, chalcomaracin, norartocarpetin, moracin L, moracin M, moracin C, curcumin, gallic acid, caffeic acid, rutin, quercitrin, quercetin, catechin, kaempferol, chlorogenic acid, and ellagic acid. Moreover, smome lignans have reported as PDE inhibitors: (+)-Medioresinol di-O-\u03b2-d-glucopyranoside, (+)- Pinoresinol di-O-\u03b2-d-glucopyranoside, (+)-Pinoresinol-4-O-\u03b2-d-glucopyranosyl (1\u21926)-\u03b2-dglucopyranoside, Liriodendrin, (+)-Pinoresinol 4'-O-\u03b2-d-glucopyranoside, and forsythin. This review provides a promising starting point of medicinal plants, which could be further studied for the development of natural phosphodiesterase inhibitors to treat diabetes mellitus. Therefore, it is important to consider clinical studies for the identification of new targets for the treatment of diabetes."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Higher Institute of Nurses Professions and Health Techniques, Oujda 60000, Morocco."}, {"Identifier": [], "Affiliation": "Laboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Department of Biology, Faculty of Sciences, Mohammed First University, BP. 717, Oujda 60040, Morocco."}], "LastName": "Ouassou", "ForeName": "Hayat", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Department of Biology, Faculty of Sciences, Mohammed First University, BP. 717, Oujda 60040, Morocco."}], "LastName": "Elhouda Daoudi", "ForeName": "Nour", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Sciences, University Mohammed First, Boulevard Mohamed VI BP 717, Oujda 60040, Morocco."}], "LastName": "Bouknana", "ForeName": "Saliha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Department of Biology, Faculty of Sciences, Mohammed First University, BP. 717, Oujda 60040, Morocco."}], "LastName": "Abdnim", "ForeName": "Rhizlan", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Department of Biology, Faculty of Sciences, Mohammed First University, BP. 717, Oujda 60040, Morocco."}], "LastName": "Bnouham", "ForeName": "Mohamed", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Med Chem", "NlmUniqueID": "101240303", "ISSNLinking": "1573-4064"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphodiesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "chemistry", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": ["pharmacology", "chemistry", "therapeutic use"], "DescriptorName": "Phosphodiesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Fu Z.; Gilbert E.R.; Liu D.; Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev 2013,9(1),25-53", "ArticleIdList": ["10.2174/157339913804143225", "22974359"]}, {"Citation": "Kalwat M.A.; Cobb M.H.; Mechanisms of the amplifying pathway of insulin secretion in the \u03b2 cell. Pharmacol Ther 2017,179,17-30", "ArticleIdList": ["10.1016/j.pharmthera.2017.05.003", "28527919"]}, {"Citation": "Tengholm A.; Cyclic AMP dynamics in the pancreatic \u03b2-cell. Ups J Med Sci 2012,117(4),355-369", "ArticleIdList": ["10.3109/03009734.2012.724732", "22970724"]}, {"Citation": "Choi Y.H.; Park S.; Hockman S.; Zmuda-Trzebiatowska E.; Svennelid F.; Haluzik M.; Gavrilova O.; Ahmad F.; Pepin L.; Napolitano M.; Taira M.; Sundler F.; Stenson Holst L.; Degerman E.; Manganiello V.C.; Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J Clin Invest 2006,116(12),3240-3251", "ArticleIdList": ["10.1172/JCI24867", "17143332"]}, {"Citation": "Kilanowska A.; Zi\u00f3\u0142kowska A.; Role of phosphodiesterase in the biology and pathology of diabetes. Int J Mol Sci 2020,21(21),8244", "ArticleIdList": ["10.3390/ijms21218244", "33153226"]}, {"Citation": "Collins S.; Surwit R.S.; The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 2001,56(1),309-328", "ArticleIdList": ["10.1210/rp.56.1.309", "11237219"]}, {"Citation": "Tian G.; S\u00e5getorp J.; Xu Y.; Shuai H.; Degerman E.; Tengholm A.; Role of phosphodiesterases in the shaping of sub-plasma membrane cAMP oscillations and pulsatile insulin secretion. J Cell Sci 2012,125(Pt 21),jcs.107201", "ArticleIdList": ["10.1242/jcs.107201", "22946044"]}, {"Citation": "Kholodenko B.N.; Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 2006,7(3),165-176", "ArticleIdList": ["10.1038/nrm1838", "16482094"]}, {"Citation": "H\u00e4rndahl L.; Wierup N.; Enerb\u00e4ck S.; Mulder H.; Manganiello V.C.; Sundler F.; Degerman E.; Ahr\u00e9n B.; Holst L.S.; \u03b2-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology. J Biol Chem 2004,279(15),15214-15222", "ArticleIdList": ["10.1074/jbc.M308952200", "14736883"]}, {"Citation": "Walz H.A.; H\u00e4rndahl L.; Wierup N.; Zmuda-Trzebiatowska E.; Svennelid F.; Manganiello V.C.; Ploug T.; Sundler F.; Degerman E.; Ahr\u00e9n B.; Holst L.S.; Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B. J Endocrinol 2006,189(3),629-641", "ArticleIdList": ["10.1677/joe.1.06522", "16731793"]}, {"Citation": "Saraswati M.; Rani H.S.; Phosphodiesterases in the pathophysiology of diabetes mellitus. Int J Anal Bio-Sci 2011,34(5)"}, {"Citation": "Moya-Beltr\u00e1n A.; Rojas-Villalobos C.; D\u00edaz M.; Guiliani N.; Quatrini R.; Castro M.; Nucleotide second messenger-based signaling in extreme acidophiles of the Acidithiobacillus species complex: Partition between the core and variable gene complements. Front Microbiol 2019,10,381", "ArticleIdList": ["10.3389/fmicb.2019.00381", "30899248"]}, {"Citation": "Yang H.; Yang L.; Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy. J Mol Endocrinol 2016,57(2),R93-R108", "ArticleIdList": ["10.1530/JME-15-0316", "27194812"]}, {"Citation": "Pratt E.P.S.; Harvey K.E.; Salyer A.E.; Hockerman G.H.; Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic \u03b2-cells. PLoS One 2019,14(8),e0215188", "ArticleIdList": ["10.1371/journal.pone.0215188", "31442224"]}, {"Citation": "Seino S.; Shibasaki T.; PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev 2005,85(4),1303-1342", "ArticleIdList": ["10.1152/physrev.00001.2005", "16183914"]}, {"Citation": "Chepurny O.G.; Kelley G.G.; Dzhura I.; Leech C.A.; Roe M.W.; Dzhura E.; Li X.; Schwede F.; Genieser H.G.; Holz G.G.; PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2\u2032- O -Me-cAMP-AM in human islets of Langerhans. Am J Physiol Endocrinol Metab 2010,298(3),E622-E633", "ArticleIdList": ["10.1152/ajpendo.00630.2009", "20009023"]}, {"Citation": "Nesher R.; Anteby E.; Yedovizky M.; Warwar N.; Kaiser N.; Cerasi E.; \u03b2-cell protein kinases and the dynamics of the insulin response to glucose. Diabetes 2002,51(Suppl. 1),S68-S73", "ArticleIdList": ["10.2337/diabetes.51.2007.S68", "11815461"]}, {"Citation": "Kim J.W.; Roberts C.D.; Berg S.A.; Caicedo A.; Roper S.D.; Chaudhari N.; Imaging cyclic AMP changes in pancreatic islets of transgenic reporter mice. PLoS One 2008,3(5),e2127", "ArticleIdList": ["10.1371/journal.pone.0002127", "18461145"]}, {"Citation": "Kasai H.; Suzuki T.; Liu T.T.; Kishimoto T.; Takahashi N.; Fast and cAMP-sensitive mode of Ca(2+)-dependent exocytosis in pancreatic \u03b2-cells. Diabetes 2002,51(Suppl. 1),S19-S24", "ArticleIdList": ["10.2337/diabetes.51.2007.S19", "11815452"]}, {"Citation": "Takahashi N.; Kadowaki T.; Yazaki Y.; Ellis-Davies G.C.R.; Miyashita Y.; Kasai H.; Post-priming actions of ATP on Ca 2+ -dependent exocytosis in pancreatic beta cells. Proc Natl Acad Sci 1999,96(2),760-765", "ArticleIdList": ["10.1073/pnas.96.2.760", "9892707"]}, {"Citation": "Doyle M.E.; Egan J.M.; Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 2007,113(3),546-593", "ArticleIdList": ["10.1016/j.pharmthera.2006.11.007", "17306374"]}, {"Citation": "Azevedo M.F.; Faucz F.R.; Bimpaki E.; Horvath A.; Levy I.; de Alexandre R.B.; Ahmad F.; Manganiello V.; Stratakis C.A.; Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev 2014,35(2),195-233", "ArticleIdList": ["10.1210/er.2013-1053", "24311737"]}, {"Citation": "Furman B.; Ong W.K.; Pyne N.J.; Cyclic AMP signaling in pancreatic islets. Adv Exp Med Biol 2010,654,581-304"}, {"Citation": "Altarejos J.Y.; Montminy M.; CREB and the CRTC co-activators: Sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 2011,12(3),141-151", "ArticleIdList": ["10.1038/nrm3072", "21346730"]}, {"Citation": "Friebe A.; Sandner P.; Schmidtko A.; cGMP: A unique 2nd messenger molecule \u2013 recent developments in cGMP research and development. Naunyn Schmiedebergs Arch Pharmacol 2020,393(2),287-302", "ArticleIdList": ["10.1007/s00210-019-01779-z", "31853617"]}, {"Citation": "Russell C.D.; Millar J.E.; Baillie J.K.; Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020,395(10223),473-475", "ArticleIdList": ["10.1016/S0140-6736(20)30317-2", "32043983"]}, {"Citation": "Undank S.; Kaiser J.; Sikimic J.; D\u00fcfer M.; Krippeit-Drews P.; Drews G.; Atrial natriuretic peptide affects stimulus-secretion coupling of pancreatic \u03b2-cells. Diabetes 2017,66(11),2840-2848", "ArticleIdList": ["10.2337/db17-0392", "28864549"]}, {"Citation": "Nystr\u00f6m T.; Orts\u00e4ter H.; Huang Z.; Zhang F.; Larsen F.J.; Weitzberg E.; Lundberg J.O.; Sj\u00f6holm \u00c5.; Inorganic nitrite stimulates pancreatic islet blood flow and insulin secretion. Free Radic Biol Med 2012,53(5),1017-1023", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.06.031", "22750508"]}, {"Citation": "Choi B-M.; Pae H-O.; Jang S-I.; Kim Y-M.; Chung H-T.; Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 2002,35(1),116-126", "ArticleIdList": ["16248976"]}, {"Citation": "Shao Y.; Huang M.; Cui W.; Feng L.J.; Wu Y.; Cai Y.; Li Z.; Zhu X.; Liu P.; Wan Y.; Ke H.; Luo H.B.; Discovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agent. J Med Chem 2014,57(24),10304-10313", "ArticleIdList": ["10.1021/jm500836h", "25432025"]}, {"Citation": "Pyne N.J.; Furman B.L.; Cyclic nucleotide phosphodiesterases in pancreatic islets. Diabetologia 2003,46(9),1179-1189", "ArticleIdList": ["10.1007/s00125-003-1176-7", "12904862"]}, {"Citation": "Schett G.; Sloan V.S.; Stevens R.M.; Schafer P.; Apremilast: A novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases. Ther Adv Musculoskelet Dis 2010,2(5),271-278", "ArticleIdList": ["10.1177/1759720X10381432", "22870453"]}, {"Citation": "Banner K.H.; Press N.J.; Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease. Br J Pharmacol 2009,157(6),892-906", "ArticleIdList": ["10.1111/j.1476-5381.2009.00170.x", "19508401"]}, {"Citation": "Heimann E.; Jones H.A.; Resj\u00f6 S.; Manganiello V.C.; Stenson L.; Degerman E.; Expression and regulation of cyclic nucleotide phosphodiesterases in human and rat pancreatic islets. PLoS One 2010,5(12),e14191", "ArticleIdList": ["10.1371/journal.pone.0014191", "21152070"]}, {"Citation": "Waddleton D.; Wu W.; Feng Y.; Thompson C.; Wu M.; Zhou Y.P.; Howard A.; Thornberry N.; Li J.; Mancini J.A.; Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets. Biochem Pharmacol 2008,76(7),884-893", "ArticleIdList": ["10.1016/j.bcp.2008.07.025", "18706893"]}, {"Citation": "Ahmad M.; Abdel-Wahab Y.H.A.; Tate R.; Flatt P.R.; Pyne N.J.; Furman B.L.; Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11. Br J Pharmacol 2000,129(6),1228-1234", "ArticleIdList": ["10.1038/sj.bjp.0703165", "10725272"]}, {"Citation": "Shafiee-Nick R.; Pyne N.J.; Furman B.L.; Effects of type\u2010selective phosphodiesterase inhibitors on glucose\u2010induced insulin secretion and islet phosphodiesterase activity. Br J Pharmacol 1995,115(8),1486-1492", "ArticleIdList": ["10.1111/j.1476-5381.1995.tb16641.x", "8564209"]}, {"Citation": "Andersson K-E.; PDE5 inhibitors \u2013 pharmacology and clinical applications 20 years after sildenafil discovery. Br J Pharmacol 2018,175(13),2554-2565", "ArticleIdList": ["10.1111/bph.14205", "29667180"]}, {"Citation": "Zhao Z.; Low Y.S.; Armstrong N.A.; Ryu J.H.; Sun S.A.; Arvanites A.C.; Hollister-Lock J.; Shah N.H.; Weir G.C.; Annes J.P.; Repurposing cAMP-modulating medications to promote \u03b2-cell replication. Mol Endocrinol 2014,28(10),1682-1697", "ArticleIdList": ["10.1210/me.2014-1120", "25083741"]}, {"Citation": "Gepts W.; Islet changes suggesting a possible immune aetiology of human diabetes mellitus. Acta Endocrinol Suppl 1976,205,95-106", "ArticleIdList": ["793281"]}, {"Citation": "Bottazzo G.F.; Dean B.M.; McNally J.M.; MacKay E.H.; Swift P.G.F.; Gamble D.R.; In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985,313(6),353-360", "ArticleIdList": ["10.1056/NEJM198508083130604", "3159965"]}, {"Citation": "Roep B.O.; The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure. Diabetologia 2003,46(3),305-321", "ArticleIdList": ["10.1007/s00125-003-1089-5", "12687328"]}, {"Citation": "Malik A.; Morya R.K.; Bhadada S.K.; Rana S.; Type 1 diabetes mellitus: Complex interplay of oxidative stress, cytokines, gastrointestinal motility and small intestinal bacterial overgrowth. Eur J Clin Invest 2018,48(11),e13021", "ArticleIdList": ["10.1111/eci.13021", "30155878"]}, {"Citation": "Asmat U.; Abad K.; Ismail K.; Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm J 2016,24(5),547-553", "ArticleIdList": ["10.1016/j.jsps.2015.03.013", "27752226"]}, {"Citation": "Wang K.; Li F.; Cui Y.; Cui C.; Cao Z.; Xu K.; Han S.; Zhu P.; Sun Y.; The association between depression and type 1 diabetes mellitus: Inflammatory cytokines as ferrymen in between? Mediators Inflamm 2019,2019,2987901"}, {"Citation": "Emanuelli B.; Glondu M.; Filloux C.; Peraldi P.; Van Obberghen E.; The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells. Diabetes 2004,53(Suppl. 3),S97-S103", "ArticleIdList": ["10.2337/diabetes.53.suppl_3.S97", "15561930"]}, {"Citation": "Cnop M.; Welsh N.; Jonas J.C.; J\u00f6rns A.; Lenzen S.; Eizirik D.L.; Mechanisms of pancreatic \u03b2-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes 2005,54(Suppl. 2),S97-S107", "ArticleIdList": ["10.2337/diabetes.54.suppl_2.S97", "16306347"]}, {"Citation": "Souness J.E.; Aldous D.; Sargent C.; Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 2000,47(2-3),127-162", "ArticleIdList": ["10.1016/S0162-3109(00)00185-5", "10878287"]}, {"Citation": "Miller M.S.; Phosphodiesterase inhibition in the treatment of autoimmune and inflammatory diseases: Current status and potential. J Receptor Ligand Channel Res 2015,8,19-30"}, {"Citation": "Boswell-Smith V.; Spina D.; Page C.P.; Phosphodiesterase inhibitors. Br J Pharmacol 2006,147(Suppl. 1),S252-S257", "ArticleIdList": ["16402111"]}, {"Citation": "Li H.; Zuo J.; Tang W.; Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases. Front Pharmacol 2018,9,1048", "ArticleIdList": ["10.3389/fphar.2018.01048", "30386231"]}, {"Citation": "Byun H.R.; Choi J.A.; Koh J.Y.; The role of metallothionein-3 in streptozotocin-induced beta-islet cell death and diabetes in mice. Metallomics 2014,6(9),1748-1757", "ArticleIdList": ["10.1039/C4MT00143E", "25054451"]}, {"Citation": "Malekifard F.; Delirezh N.; Hobbenaghi R.; Malekinejad H.; Immunotherapeutic effects of pentoxifylline in type 1 diabetic mice and its role in the response of T-helper lymphocytes. Iran J Basic Med Sci 2015,18(3),247-252", "ArticleIdList": ["25945237"]}, {"Citation": "Beshay E.; Prud\u2019homme G.J.; Inhibitors of phosphodiesterase isoforms III or IV suppress islet-cell nitric oxide production. Lab Invest 2001,81(8),1109-1117", "ArticleIdList": ["10.1038/labinvest.3780323", "11502862"]}, {"Citation": "Liang L.; Beshay E.; Prud\u2019homme G.J.; The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes 1998,47(4),570-575", "ArticleIdList": ["10.2337/diabetes.47.4.570", "9568689"]}, {"Citation": "Badger A.M.; Olivera D.L.; Esser K.M.; Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Circ Shock 1994,44(4),188-195"}, {"Citation": "Fang L.; Radovits T.; Szab\u00f3 G.; M\u00f3zes M.M.; Rosivall L.; K\u00f6k\u00e9ny G.; Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3\u2032,5\u2032 guanosine monophosphate (cGMP) level in podocytes. Nephrol Dial Transplant 2013,28(7),1751-1761", "ArticleIdList": ["10.1093/ndt/gfs391", "23203993"]}, {"Citation": "Goldstein I.; Young J.M.; Fischer J.; Bangerter K.; Segerson T.; Taylor T.; Group V.D.S.; Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 2003,26(3),777-783", "ArticleIdList": ["10.2337/diacare.26.3.777", "12610037"]}, {"Citation": "Caruso S.; Rugolo S.; Agnello C.; Intelisano G.; Di Mari L.; Cianci A.; Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: A double-blind, crossover, placebo-controlled pilot study. Fertil Steril 2006,85(5),1496-1501", "ArticleIdList": ["10.1016/j.fertnstert.2005.10.043", "16579999"]}, {"Citation": "Balhara Y.P.; Sarkar S.; Gupta R.; Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Indian J Endocrinol Metab 2015,19(4),451-461", "ArticleIdList": ["10.4103/2230-8210.159023", "26180759"]}, {"Citation": "Behrend L.; Vibe-Petersen J.; Perrild H.; Sildenafil in the treatment of erectile dysfunction in men with diabetes: Demand, efficacy and patient satisfaction. Int J Impot Res 2005,17(3),264-269", "ArticleIdList": ["10.1038/sj.ijir.3901302", "15674401"]}, {"Citation": "Rendell M.S.; Rajfer J.; Wicker P.A.; Smith M.D.; Group S.D.S.; Group S.D.S.; Sildenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial. JAMA 1999,281(5),421-426", "ArticleIdList": ["10.1001/jama.281.5.421", "9952201"]}, {"Citation": "Wondmkun Y.T.; Obesity, insulin resistance, and type 2 diabetes: Associations and therapeutic implications. Diabetes Metab Syndr Obes 2020,13,3611-3616", "ArticleIdList": ["10.2147/DMSO.S275898", "33116712"]}, {"Citation": "Ginsberg H.N.; Insulin resistance and cardiovascular disease. J Clin Invest 2000,106(4),453-458", "ArticleIdList": ["10.1172/JCI10762", "10953019"]}, {"Citation": "Cusi K.; Maezono K.; Osman A.; Pendergrass M.; Patti M.E.; Pratipanawatr T.; DeFronzo R.A.; Kahn C.R.; Mandarino L.J.; Insulin resistance differentially affects the PI 3-kinase\u2013 and MAP kinase\u2013mediated signaling in human muscle. J Clin Invest 2000,105(3),311-320", "ArticleIdList": ["10.1172/JCI7535", "10675357"]}, {"Citation": "Bouzakri K.; Koistinen H.; Zierath J.; Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes. Curr Diabetes Rev 2005,1(2),167-174", "ArticleIdList": ["10.2174/1573399054022785", "18220592"]}, {"Citation": "Karlsson H.K.R.; Zierath J.R.; Insulin signaling and glucose transport in insulin resistant human skeletal muscle. Cell Biochem Biophys 2007,48(2-3),103-113", "ArticleIdList": ["10.1007/s12013-007-0030-9", "17709880"]}, {"Citation": "Saisho Y.; \u03b2-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes 2015,6(1),109-124", "ArticleIdList": ["10.4239/wjd.v6.i1.109", "25685282"]}, {"Citation": "Oguntibeju O.O.; Type 2 diabetes mellitus, oxidative stress and inflammation: Examining the links. Int J Physiol Pathophysiol Pharmacol 2019,11(3),45-63", "ArticleIdList": ["31333808"]}, {"Citation": "Eguchi N.; Vaziri N.D.; Dafoe D.C.; Ichii H.; The role of oxidative stress in pancreatic \u03b2 cell dysfunction in diabetes. Int J Mol Sci 2021,22(4),1509", "ArticleIdList": ["10.3390/ijms22041509", "33546200"]}, {"Citation": "Wang J.; Wang H.; Oxidative stress in pancreatic beta cell regeneration. Oxid Med Cell Longev 2017,2017,1930261", "ArticleIdList": ["10.1155/2017/1930261"]}, {"Citation": "H\u00e4rndahl L.; Jing X.J.; Ivarsson R.; Degerman E.; Ahr\u00e9n B.; Manganiello V.C.; Renstr\u00f6m E.; Holst L.S.; Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic \u03b2-cell exocytosis and release of insulin. J Biol Chem 2002,277(40),37446-37455", "ArticleIdList": ["10.1074/jbc.M205401200", "12169692"]}, {"Citation": "Muhammed S.J.; Lundquist I.; Salehi A.; Pancreatic \u03b2\u2010cell dysfunction, expression of INOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes. Diabetes Obes Metab 2012,14(11),1010-1019", "ArticleIdList": ["10.1111/j.1463-1326.2012.01632.x", "22687049"]}, {"Citation": "Parker J.C.; Vanvolkenburg M.A.; Nardone N.A.; Hargrove D.M.; Andrews K.M.; Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III. Biochem Biophys Res Commun 1997,236(3),665-669", "ArticleIdList": ["10.1006/bbrc.1997.7034", "9245710"]}, {"Citation": "El-Metwally M.; Shafiee-Nick R.; Pyne N.J.; Furman B.L.; The effect of selective phosphodiesterase inhibitors on plasma insulin concentrations and insulin secretion in vitro in the rat. Eur J Pharmacol 1997,324(2-3),227-232", "ArticleIdList": ["10.1016/S0014-2999(97)00076-9", "9145777"]}, {"Citation": "Snyder P.B.; The adipocyte cGMP-inhibited cyclic nucleotide phosphodiesterase (PDE3B) as a target for lipolytic and thermogenic agents for the treatment of obesity. Emerg Therap Targets 1999,3(4),587-599", "ArticleIdList": ["10.1517/14728222.3.4.587"]}, {"Citation": "Park S.Y.; Shin H.K.; Lee J.H.; Kim C.D.; Lee W.S.; Rhim B.Y.; Hong K.W.; Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor \u03b3 transcription. J Pharmacol Exp Ther 2009,329(2),571-579", "ArticleIdList": ["10.1124/jpet.108.146456", "19221061"]}, {"Citation": "Chang S.A.; Cha B.Y.; Yoo S.J.; Ahn Y.B.; Song K.H.; Han J.H.; Lee J.M.; Son H.S.; Yoon K.H.; Kang M.I.; Lee K.W.; Son H.Y.; Kang S.K.; The effect of cilostazol on glucose tolerance and insulin resistance in a rat model of non-insulin dependent diabetes mellitus. Korean J Intern Med 2001,16(2),87-92", "ArticleIdList": ["10.3904/kjim.2001.16.2.87", "11590907"]}, {"Citation": "Wada T.; Onogi Y.; Kimura Y.; Nakano T.; Fusanobori H.; Ishii Y.; Sasahara M.; Tsuneki H.; Sasaoka T.; Cilostazol ameliorates systemic insulin resistance in diabetic db/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions. Eur J Pharmacol 2013,707(1-3),120-129", "ArticleIdList": ["10.1016/j.ejphar.2013.03.016", "23528355"]}, {"Citation": "Liu J.S.; Chuang T.J.; Chen J.H.; Lee C.H.; Hsieh C.H.; Lin T.K.; Hsiao F.C.; Hung Y.J.; Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: The role of plasma soluble receptor for advanced glycation end-products. Endocrine 2015,49(3),703-710", "ArticleIdList": ["10.1007/s12020-015-0545-6", "25666934"]}, {"Citation": "Lee C.Y.; Wu T.C.; Lin S.J.; Long-term cilostazol treatment and predictive factors on outcomes of endovascular intervention in patients with diabetes mellitus and critical limb ischemia. Diabetes Ther 2020,11(8),1757-1773", "ArticleIdList": ["10.1007/s13300-020-00860-8", "32564334"]}, {"Citation": "Plock N.; Vollert S.; Mayer M.; Hanauer G.; Lahu G.; Pharmacokinetic/pharmacodynamic modeling of the PDE4 inhibitor TAK\u2010648 in Type 2 diabetes: Early translational approaches for human dose prediction. Clin Transl Sci 2017,10(3),185-193", "ArticleIdList": ["10.1111/cts.12436", "28088839"]}, {"Citation": "Wouters E.F.M.; Bredenbr\u00f6ker D.; Teichmann P.; Brose M.; Rabe K.F.; Fabbri L.M.; G\u00f6ke B.; Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus. J Clin Endocrinol Metab 2012,97(9),E1720-E1725", "ArticleIdList": ["10.1210/jc.2011-2886", "22723325"]}, {"Citation": "Marampon F.; Antinozzi C.; Corinaldesi C.; Vannelli G.B.; Sarchielli E.; Migliaccio S.; Di Luigi L.; Lenzi A.; Crescioli C.; The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism. Endocrine 2018,59(3),602-613", "ArticleIdList": ["10.1007/s12020-017-1378-2", "28786077"]}, {"Citation": "Aversa A.; Fittipaldi S.; Francomano D.; Bimonte V.M.; Greco E.A.; Crescioli C.; Di Luigi L.; Lenzi A.; Migliaccio S.; Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: In vivo and in vitro characterization. Endocrine 2017,56(3),639-648", "ArticleIdList": ["10.1007/s12020-016-1208-y", "28133708"]}, {"Citation": "Yu H.M.; Chung H.K.; Kim K.S.; Lee J.M.; Hong J.H.; Park K.S.; PDE 5 inhibitor improves insulin sensitivity by enhancing mitochondrial function in adipocytes. Biochem Biophys Res Commun 2017,493(1),631-636", "ArticleIdList": ["10.1016/j.bbrc.2017.08.140", "28888986"]}, {"Citation": "Aversa A.; Systemic and metabolic effects of PDE5-inhibitor drugs. World J Diabetes 2010,1(1),3-7", "ArticleIdList": ["10.4239/wjd.v1.i1.3", "21537421"]}, {"Citation": "Sabatini S.; Sgr\u00f2 P.; Duranti G.; Ceci R.; Di Luigi L.; Tadalafil alters energy metabolism in C2C12 skeletal muscle cells. Acta Biochim Pol 2011,58(2),237-241", "ArticleIdList": ["10.18388/abp.2011_2271", "21681286"]}, {"Citation": "Crescioli C.; Sturli N.; Sottili M.; Bonini P.; Lenzi A.; Di Luigi L.; Insulin-like effect of the phosphodiesterase type 5 inhibitor tadalafil onto male human skeletal muscle cells. J Endocrinol Invest 2013,36(11),1020-1026", "ArticleIdList": ["23873283"]}, {"Citation": "Bergandi L.; Silvagno F.; Russo I.; Riganti C.; Anfossi G.; Aldieri E.; Ghigo D.; Trovati M.; Bosia A.; Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003,23(12),2215-2221", "ArticleIdList": ["10.1161/01.ATV.0000107028.20478.8e", "14615391"]}, {"Citation": "Mandosi E.; Giannetta E.; Filardi T.; Lococo M.; Bertolini C.; Fallarino M.; Gianfrilli D.; Venneri M.A.; Lenti L.; Lenzi A.; Morano S.; Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes. Expert Opin Ther Targets 2015,19(12),1617-1622", "ArticleIdList": ["10.1517/14728222.2015.1066337", "26178526"]}, {"Citation": "Ayala J.E.; Bracy D.P.; Julien B.M.; Rottman J.N.; Fueger P.T.; Wasserman D.H.; Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes 2007,56(4),1025-1033", "ArticleIdList": ["10.2337/db06-0883", "17229936"]}, {"Citation": "Sandner P.; From molecules to patients: Exploring the therapeutic role of soluble guanylate cyclase stimulators. Biol Chem 2018,399(7),679-690", "ArticleIdList": ["10.1515/hsz-2018-0155", "29604206"]}, {"Citation": "DeNinno M.P.; Andrews M.; Bell A.S.; Chen Y.; Eller-Zarbo C.; Eshelby N.; Etienne J.B.; Moore D.E.; Palmer M.J.; Visser M.S.; Yu L.J.; Zavadoski W.J.; Michael Gibbs E.; The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents. Bioorg Med Chem Lett 2009,19(9),2537-2541", "ArticleIdList": ["10.1016/j.bmcl.2009.03.024", "19339180"]}, {"Citation": "Kleiman R.J.; Chapin D.S.; Christoffersen C.; Freeman J.; Fonseca K.R.; Geoghegan K.F.; Grimwood S.; Guanowsky V.; Haj\u00f3s M.; Harms J.F.; Helal C.J.; Hoffmann W.E.; Kocan G.P.; Majchrzak M.J.; McGinnis D.; McLean S.; Menniti F.S.; Nelson F.; Roof R.; Schmidt A.W.; Seymour P.A.; Stephenson D.T.; Tingley F.D.; Vanase-Frawley M.; Verhoest P.R.; Schmidt C.J.; Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo. J Pharmacol Exp Ther 2012,341(2),396-409", "ArticleIdList": ["10.1124/jpet.111.191353", "22328573"]}, {"Citation": "Kroker K.S.; Rast G.; Giovannini R.; Marti A.; Dorner-Ciossek C.; Rosenbrock H.; Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. Neuropharmacology 2012,62(5-6),1964-1974", "ArticleIdList": ["10.1016/j.neuropharm.2011.12.021", "22245562"]}, {"Citation": "Vardigan J.D.; Converso A.; Hutson P.H.; Uslaner J.M.; The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task. J Neurogenet 2011,25(4),120-126", "ArticleIdList": ["10.3109/01677063.2011.630494", "22070409"]}, {"Citation": "Dias D.A.; Urban S.; Roessner U.; A historical overview of natural products in drug discovery. Metabolites 2012,2(2),303-336", "ArticleIdList": ["10.3390/metabo2020303", "24957513"]}, {"Citation": "Yuan H.; Ma Q.; Ye L.; Piao G.; The traditional medicine and modern medicine from natural products. Molecules 2016,21(5),559", "ArticleIdList": ["10.3390/molecules21050559", "27136524"]}, {"Citation": "Abdelsalam N.R.; Hasan M.E.; Javed T.; Rabie S.M.A.; El-Wakeel H.E.D.M.F.; Zaitoun A.F.; Abdelsalam A.Z.; Aly H.M.; Ghareeb R.Y.; Hemeida A.A.; Shah A.N.; Endorsement and phylogenetic analysis of some Fabaceae plants based on DNA barcoding. Mol Biol Rep 2022,49(6),5645-5657", "ArticleIdList": ["10.1007/s11033-022-07574-z", "35655052"]}, {"Citation": "Permender R.; Hema C.; Sushila R.; Dharmender R.; Vikash K.; Antidiabetic potential of Fabaceae family: An overview. Curr Nutr Food Sci 2010,6(3),161-175", "ArticleIdList": ["10.2174/157340110792389163"]}, {"Citation": "Adnan M.; Jeon B.B.; Chowdhury M.H.U.; Oh K.K.; Das T.; Chy M.N.U.; Cho D.H.; Network pharmacology study to reveal the potentiality of a methanol extract of Caesalpinia sappan L. Wood against type-2 diabetes mellitus. Life 2022,12(2),277", "ArticleIdList": ["10.3390/life12020277", "35207564"]}, {"Citation": "Rangra N.; Samanta S.; Pradhan K.; A comprehensive review on phytopharmacological investigations of Acacia auriculiformis A.Cunn. ex Benth. Asian Pac J Trop Biomed 2019,9(1),1", "ArticleIdList": ["10.4103/2221-1691.250263"]}, {"Citation": "Umaru I.J.; Samling B.; Umaru H.A.; Phytochemical screening of Etlingera elatior (torch ginger) cultivated on different dosage of biochar. Asian J Biochem Genet 2018,1(4),1-6"}, {"Citation": "Vinodhini S.; Review on ethnomedical uses, pharmacological activity and phytochemical constituents of Samanea saman (jacq.) Merr. rain tree. Pharmacogn Mag 2018,10(2),202-209"}, {"Citation": "Kazeem M.I.; Azeez G.A.; Ashafa A.O.T.; Effect of senna alata (L) roxb (fabaceae) leaf extracts on alpha-amylase, alpha-glucosidase and postprandial hyperglycemia in rats. Trop J Pharm Res 2015,14(10),1843-1848", "ArticleIdList": ["10.4314/tjpr.v14i10.15"]}, {"Citation": "Mosaddik A.; Nahar L.; Nasrin F.; Zahan R.; Haque A.; Haque E.; Comparative study of antidiabetic activity of Cajanus cajan and Tamarindus indica in alloxan-induced diabetic mice with a reference to in vitro antioxidant activity. Pharmacognosy Res 2014,6(2),180-187", "ArticleIdList": ["10.4103/0974-8490.129043", "24761124"]}, {"Citation": "Badami S.; Moorkoth S.; Rai S.R.; Kannan E.; Bhojraj S.; Antioxidant activity of caesalpinia sappan heartwood. Biol Pharm Bull 2003,26(11),1534-1537", "ArticleIdList": ["10.1248/bpb.26.1534", "14600396"]}, {"Citation": "Singh R.; Singh S.; Kumar S.; Arora S.; Evaluation of antioxidant potential of ethyl acetate extract/fractions of Acacia auriculiformis A. Cunn Food Chem Toxicol 2007,45(7),1216-1223", "ArticleIdList": ["10.1016/j.fct.2007.01.002", "17336438"]}, {"Citation": "Chowtivannakul P.; Srichaikul B.; Talubmook C.; Antidiabetic and antioxidant activities of seed extract from Leucaena leucocephala (Lam.) de Wit. Agric Nat Resour 2016,50(5),357-361", "ArticleIdList": ["10.1016/j.anres.2016.06.007"]}, {"Citation": "Escalona-Arranz J.C.; Perez-Ros\u00e9s R.; Rodr\u00edguez-Amado J.; Morris-Quevedo H.J.; Mwasi L.B.; Cabrera-Sotomayor O.; Machado-Garc\u00eda R.; Fong-L\u00f3rez O.; Alfonso-Castillo A.; Puente-Zapata E.; Antioxidant and toxicological evaluation of a Tamarindus indica L. leaf fluid extract. Nat Prod Res 2016,30(4),456-459", "ArticleIdList": ["10.1080/14786419.2015.1019350", "25752793"]}, {"Citation": "Milani E.; Nikfar S.; Khorasani R.; Zamani M.J.; Abdollahi M.; Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp Biochem Physiol C Toxicol Pharmacol 2005,140(2),251-255", "ArticleIdList": ["10.1016/j.cca.2005.02.010", "15907769"]}, {"Citation": "Barbagallo F.; Campolo F.; Franceschini E.; Crecca E.; Pofi R.; Isidori A.M.; Venneri M.A.; PDE5 inhibitors in type 2 diabetes cardiovascular complications. Endocrines 2020,1(2),90-101", "ArticleIdList": ["10.3390/endocrines1020009"]}, {"Citation": "Li X.; Zhao Q.; Wang J.; Wang J.; Dai H.; Li H.; Wang B.; Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction. Medicine 2018,97(40),e12559", "ArticleIdList": ["10.1097/MD.0000000000012559", "30290616"]}, {"Citation": "Poolsup N.; Suksomboon N.; Aung N.; Effect of phosphodiesterase-5 inhibitors on glycemic control in person with type 2 diabetes mellitus: A systematic review and meta-analysis. J Clin Transl Endocrinol 2016,6,50-55", "ArticleIdList": ["10.1016/j.jcte.2016.11.003", "29067241"]}, {"Citation": "Tran N.; Pham B.; Le L.; Bioactive compounds in anti-diabetic plants: From herbal medicine to modern drug discovery. Biology 2020,9(9),252", "ArticleIdList": ["10.3390/biology9090252", "32872226"]}, {"Citation": "Anand Ganapathy A.; Hari Priya V.M.; Kumaran A.; Medicinal plants as a potential source of Phosphodiesterase-5 inhibitors: A review. J Ethnopharmacol 2021,267,113536", "ArticleIdList": ["10.1016/j.jep.2020.113536", "33137431"]}, {"Citation": "Reneerkens O.A.H.; Rutten K.; Steinbusch H.W.M.; Blokland A.; Prickaerts J.; Selective phosphodiesterase inhibitors: A promising target for cognition enhancement. Psychopharmacology 2009,202(1-3),419-443", "ArticleIdList": ["10.1007/s00213-008-1273-x", "18709359"]}, {"Citation": "Ribaudo G.; Memo M.; Gianoncelli A.; A perspective on natural and nature-inspired small molecules targeting phosphodiesterase 9 (PDE9): Chances and challenges against neurodegeneration. Pharmaceuticals 2021,14(1),58", "ArticleIdList": ["10.3390/ph14010058", "33451065"]}, {"Citation": "Abusnina A.; Lugnier C.; Therapeutic potentials of natural compounds acting on cyclic nucleotide phosphodiesterase families. Cell Signal 2017,39,55-65", "ArticleIdList": ["10.1016/j.cellsig.2017.07.018", "28754627"]}, {"Citation": "Chit K.; Myint W.; Thein K.; Maw W.W.; Myint M.M.; Than A.; Khin M.; Cyclic AMP phosphodiesterase inhibitory activity and chemical screening of four medicinal plants. Pharm Biol 2001,39(3),181-183", "ArticleIdList": ["10.1076/phbi.39.3.181.5932"]}, {"Citation": "Fozing C.; Ali Z.; Ngadjui B.; Choudhary M.; Kapche G.; Abegaz B.; Khan I.; Phosphodiesterase I-inhibiting Diels-Alder adducts from the leaves of Morus mesozygia. Planta Med 2012,78(2),154-159", "ArticleIdList": ["10.1055/s-0031-1280338", "22083899"]}, {"Citation": "Chen S.K.; Zhao P.; Shao Y.X.; Li Z.; Zhang C.; Liu P.; He X.; Luo H.B.; Hu X.; Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor. Bioorg Med Chem Lett 2012,22(9),3261-3264", "ArticleIdList": ["10.1016/j.bmcl.2012.03.026", "22483586"]}, {"Citation": "Kruangtip O.; Chootip K.; Temkitthawon P.; Changwichit K.; Chuprajob T.; Changtam C.; Suksamrarn A.; Khorana N.; Scholfield C.N.; Ingkaninan K.; Curcumin analogues inhibit phosphodiesterase-5 and dilate rat pulmonary arteries. J Pharm Pharmacol 2014,67(1),87-95", "ArticleIdList": ["10.1111/jphp.12302", "25176340"]}, {"Citation": "Oboh G.; Ademiluyi A.O.; Oyeleye S.I.; Olasehinde T.A.; Boligon A.A.; Modulation of some markers of erectile dysfunction and malonaldehyde levels in isolated rat penile tissue with unripe and ripe plantain peels: Identification of the constituents of the plants using HPLC. Pharm Biol 2017,55(1),1920-1926", "ArticleIdList": ["10.1080/13880209.2017.1340966", "28651482"]}, {"Citation": "Oboh G.; Adebayo A.A.; Ademosun A.O.; Effects of water extractable phytochemicals of mahogany (Swietenia macrophylla) and axlewood (Anogeissus leiocarpus) stem bark on some enzymes implicated in erectile dysfunction and type-2 diabetes. J Food Biochem 2017,41(6),e12430", "ArticleIdList": ["10.1111/jfbc.12430"]}, {"Citation": "Nikaido T.; Ohmoto T.; Noguchi H.; Kinoshita T.; Saitoh H.; Sankawa U.; Inhibitors of cyclic AMP phosphodiesterase in medicinal plants. Planta Med 1981,43(9),18-23", "ArticleIdList": ["10.1055/s-2007-971466", "6285403"]}, {"Citation": "Shi S.Y.; Peng M.J.; Zhang Y.P.; Peng S.; Combination of preparative HPLC and HSCCC methods to separate phosphodiesterase inhibitors from Eucommia ulmoides bark guided by ultrafiltration-based ligand screening. Anal Bioanal Chem 2013,405(12),4213-4223", "ArticleIdList": ["10.1007/s00216-013-6806-4", "23404133"]}, {"Citation": "Coon T.A.; McKelvey A.C.; Weathington N.M.; Birru R.L.; Lear T.; Leikauf G.D.; Chen B.B.; Novel PDE4 inhibitors derived from Chinese medicine forsythia. PLoS One 2014,9(12),e115937", "ArticleIdList": ["10.1371/journal.pone.0115937", "25549252"]}, {"Citation": "Shah Z.A.; Abu-Izneid T.; Rauf A.; Rashid U.; Nizam M.; Muhammad N.; Rengasamy K.R.R.; Phosphodiesterase 1 inhibition and molecular docking study of phytochemicals isolated from stem heartwood of Heterophragma adenophyllum Seem. S Afr J Bot 2020,135,274-279", "ArticleIdList": ["10.1016/j.sajb.2020.08.013"]}, {"Citation": "Mostafa M.; Nahar N.; Mosihuzzaman M.; Sokeng S.D.; Fatima N.; Atta-ur-Rahman ; Choudhary M.I.; Phosphodiesterase-I inhibitor quinovic acid glycosides fromBridelia ndellensis. Nat Prod Res 2006,20(7),686-692", "ArticleIdList": ["10.1080/14786410600661658", "16901813"]}, {"Citation": "Povolo C.; Foschini A.; Ribaudo G.; Optimization of the extraction of bioactive molecules from Lycium barbarum fruits and evaluation of the antioxidant activity: A combined study. Nat Prod Res 2019,33(18),2694-2698", "ArticleIdList": ["10.1080/14786419.2018.1460835", "29667524"]}, {"Citation": "Omodanisi E.; Aboua Y.; Oguntibeju O.; Assessment of the anti-hyperglycaemic, anti-inflammatory and antioxidant activities of the methanol extract of Moringa oleifera in diabetes-induced nephrotoxic male wistar rats. Molecules 2017,22(4),439", "ArticleIdList": ["10.3390/molecules22040439", "28333074"]}, {"Citation": "Khairullah A.R.; Solikhah T.I.; Ansori A.N.M.; Fadholly A.; Ram S.C.; Ansharieta R.; Widodo A.; Riwu K.H.P.; Putri N.; Proboningrat A.; A review of an important medicinal plant: Alpinia galanga (L.) willd. Sys Rev Pharm 2020,11(10),387-395"}, {"Citation": "Wang Y.; Dan Y.; Yang D.; Hu Y.; Zhang L.; Zhang C.; Zhu H.; Cui Z.; Li M.; Liu Y.; The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology. J Ethnopharmacol 2014,153(1),42-60", "ArticleIdList": ["10.1016/j.jep.2014.02.013", "24556224"]}, {"Citation": "Shikov A.N.; Pozharitskaya O.N.; Makarov V.G.; Aralia elata var. mandshurica (Rupr. and Maxim.) J. Wen: An overview of pharmacological studies. Phytomedicine 2016,23(12),1409-1421", "ArticleIdList": ["10.1016/j.phymed.2016.07.011", "27765361"]}, {"Citation": "He X.; Wang J.; Li M.; Hao D.; Yang Y.; Zhang C.; He R.; Tao R.; Eucommia ulmoides Oliv.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol 2014,151(1),78-92", "ArticleIdList": ["10.1016/j.jep.2013.11.023", "24296089"]}, {"Citation": "Fakhrudin N.; Nurrochmad A.; Sudarmanto A.; Ikawati Z.; Caesalpinia sappan L. wood is a potential source of natural phosphodiesterase-1 inhibitors. Pharmacogn Mag 2020,12(6)"}, {"Citation": "Kaur H.; Amini M.H.; Prabhakar P.K.; Singh A.; Suttee A.; Phytochemical screening and antimicrobial activity of Caesalpinia sappan L. leaves. Int J Pharmacogn Phytochem 2016,8(6),1040-1045"}, {"Citation": "Tirwomwe M.; Echoru I.; Maseruka R.; Kimanje K.R.; Byarugaba W.; Hypoglycemic and toxic effect of morus mesozygia leaf extract on the liver and kidneys of alloxan-induced hyperglycemic wistar rats. Evid Based Complement Alternat Med 2019,2019,6712178"}, {"Citation": "Sowunmi A.; Aderibigbe A.; Olusegun A.; Evaluation of antidepressant-like effect of morus mesozygia extract in mice: The monoaminergic involvement. IJRSI 2020,7(2),1-6"}, {"Citation": "Sokeng S.D.; Rokeya B.; Hannan J.M.A.; Ali L.; Kamtchouing P.; The antihyperglycemic effect of Bridelia ndellensis ethanol extract and its fractions is mediated by an insulinotropic action. J Diabetes Mellit 2013,3,114-115"}, {"Citation": "Devi B.; Sharma N.; Kumar D.; Jeet K.; Morus alba Linn: A phytopharmacological review. Int J Pharm Pharm Sci 2013,5(2),14-18"}, {"Citation": "Kumar S.; Yadav J.; Ethnobotanical and pharmacological properties of Aloe vera: A review. J Med Plants Res 2014,8(48),1387-1398"}, {"Citation": "Zhong J.; Huang Y.; Ding W.; Wu X.; Wan J.; Luo H.; Chemical constituents of Aloe barbadensis Miller and their inhibitory effects on phosphodiesterase-4D. Fitoterapia 2013,91,159-165", "ArticleIdList": ["10.1016/j.fitote.2013.08.027", "24028970"]}, {"Citation": "Zhang Y.; Feng F.; Chen T.; Li Z.; Shen Q.W.; Antidiabetic and antihyperlipidemic activities of Forsythia suspensa (Thunb.) Vahl (fruit) in streptozotocin-induced diabetes mice. J Ethnopharmacol 2016,192,256-263", "ArticleIdList": ["10.1016/j.jep.2016.07.002", "27377336"]}, {"Citation": "Kumar N.; Sakhya S.; Ethnopharmacological properties of curcuma longa: A review. IJPSR 2013,4(1),103-112"}, {"Citation": "Temkitthawon P.; Hinds T.R.; Beavo J.A.; Viyoch J.; Suwanborirux K.; Pongamornkul W.; Sawasdee P.; Ingkaninan K.; Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors. J Ethnopharmacol 2011,137(3),1437-1441", "ArticleIdList": ["10.1016/j.jep.2011.08.025", "21884777"]}, {"Citation": "Sharma A.; Shetty M.; Parida A.; Adiga S.; Kamath S.; Sowjanya, ; Effect of ethanolic extract of Acacia auriculiformis leaves on learning and memory in rats. Pharmacognosy Res 2014,6(3),246-250", "ArticleIdList": ["10.4103/0974-8490.132605", "25002806"]}, {"Citation": "Sinou C.; Forest F.; Lewis G.P.; Bruneau A.; The genus Bauhinia s.l. (Leguminosae): A phylogeny based on the plastid trn L\u2013 trn F region. Botany 2009,87(10),947-960", "ArticleIdList": ["10.1139/B09-065"]}, {"Citation": "Siddiqua A.; Zahra M.; Begum K.; Jamil M.; The traditional uses, phytochemistry and pharmacological properties of Cassia fistula. JPP 2018,2(1),15-23"}, {"Citation": "Oboh G.; Adebayo A.A.; Ademosun A.O.; Boligon A.A.; In vitro inhibition of phosphodiesterase-5 and arginase activities from rat penile tissue by two Nigerian herbs (Hunteria umbellata and Anogeissus leiocarpus). J Basic Clin Physiol Pharmacol 2017,28(4),393-401", "ArticleIdList": ["10.1515/jbcpp-2016-0143", "28306529"]}, {"Citation": "Oboh G.; Adebayo A.A.; Ademosun A.O.; Erection-stimulating, anti-diabetic and antioxidant properties of Hunteria umbellata and Cylicodiscus gabunensis water extractable phytochemicals. J Complement Integr Med 2018,15(1),0164", "ArticleIdList": ["10.1515/jcim-2016-0164", "28749782"]}, {"Citation": "Umaru I.J.; Samling B.; Umaru H.A.; Phytochemical screening of Leucaena leucocephala leaf essential oil and its antibacterial potentials. MOJ Drug Design Develop Thera 2018,2(6),224-228", "ArticleIdList": ["10.15406/mojddt.2018.02.00066"]}, {"Citation": "Soon Y.; Tan B.; Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. Singap Med J 2002,43(2),077-085"}, {"Citation": "Zhang J.; Xin H.; Xu Y.; Shen Y.; He Y.Q.; Hsien-Yeh ; Lin B.; Song H.; Juan-Liu ; Yang H.; Qin L.; Zhang Q.; Du J.; Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 2018,213,230-255", "ArticleIdList": ["10.1016/j.jep.2017.10.028", "29126988"]}, {"Citation": "Lee K-H.; Kim B-S.; Rhee K-H.; Screening of herbal medicines for phosphodiesterase 5 inhibitor. Korean J Pharmacogn 2012,43(2),184-191"}, {"Citation": "Morvin Yabesh J.E.; Prabhu S.; Vijayakumar S.; An ethnobotanical study of medicinal plants used by traditional healers in silent valley of Kerala, India. J Ethnopharmacol 2014,154(3),774-789", "ArticleIdList": ["10.1016/j.jep.2014.05.004", "24832113"]}, {"Citation": "Prabsattroo T.; Wattanathorn J.; Iamsaard S.; Somsapt P.; Sritragool O.; Thukhummee W.; Muchimapura S.; Moringa oleifera extract enhances sexual performance in stressed rats. J Zhejiang Univ Sci B 2015,16(3),179-190", "ArticleIdList": ["10.1631/jzus.B1400197", "25743119"]}, {"Citation": "Abe R.; Ohtani K.; An ethnobotanical study of medicinal plants and traditional therapies on Batan Island, the Philippines. J Ethnopharmacol 2013,145(2),554-565", "ArticleIdList": ["10.1016/j.jep.2012.11.029", "23183086"]}, {"Citation": "Oladeji O.S.; Adelowo F.E.; Oluyori A.P.; Bankole D.T.; Ethnobotanical description and biological activities of Senna alata. Evid Based Complement Alternat Med 2020,2020,2580259"}, {"Citation": "Moghadamtousi S.; Goh B.; Chan C.; Shabab T.; Kadir H.; Biological activities and phytochemicals of Swietenia macrophylla King. Molecules 2013,18(9),10465-10483", "ArticleIdList": ["10.3390/molecules180910465", "23999722"]}, {"Citation": "Meher B.; Dash D.K.; Roy A.; A review on: Phytochemistry, pharmacology and traditional uses of Tamarindus indica L. WJPPS 2014,3(10),229-240"}, {"Citation": "Ahmad W.; Jantan I.; Bukhari S.N.A.; Tinospora crispa (L.) Hook. f. and Thomson: A review of its ethnobotanical, phytochemical, and pharmacological aspects. Front Pharmacol 2016,7,59", "ArticleIdList": ["10.3389/fphar.2016.00059", "27047378"]}, {"Citation": "Brantner A.; Alajlani M.; Autz C.; Benetik S.; Plhak E.; Prinz S.; Pitakbut T.; Dej-adisai S.; Antidiabetic activity of selected indigenous Thai medicinal plants. Planta Med 2016,82(S 01),P1045", "ArticleIdList": ["10.1055/s-0036-1597023"]}, {"Citation": "Mohana D.; Raveesha K.; Anti-bacterial activity of Caesalpinia coriaria (Jacq.) Willd. against plant pathogenic Xanthomonas pathovars: An eco-friendly approach. JAST 2006,2(2),317-327"}]}], "History": [{"Year": "2023", "Month": "4", "Day": "25"}, {"Year": "2023", "Month": "7", "Day": "31"}, {"Year": "2023", "Month": "9", "Day": "25"}, {"Year": "2024", "Month": "7", "Day": "8", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "24", "Hour": "12", "Minute": "44"}, {"Year": "2024", "Month": "1", "Day": "24", "Hour": "10", "Minute": "33"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38265379", "10.2174/0115734064255060231116192839", "MC-EPUB-137684"]}}]}